None listed
Conditions
Brief summary
The aim of this project is to assess the impact of providing longer term tube feeding in patients with oesophageal cancer who are undergoing oesophagectomy. Who is it for? You may be eligible to join this study if you are aged 18 years or over and a have oesophageal cancer undergoing oesophagectomy at the John Hunter Hospital, NSW. Study details Study participants will be allocated by chance to either the intervention of the standard care control group. Participants in the intervention group will receive a tube feed supplying 20kCal/kg and 1g/kg protein per day (approx. 60-70% of requirements) for 12 weeks post operatively compared to a control group who will be tube fed at the same level (20kCal/kg and 1g/kg Protein) for the usual period of six weeks. On discharge all patients will be provided with standardised education regarding appropriate high energy and high protein foods and be guided through the process of reintroducing foods from puree to soft texture. It is hoped that this study will help us understand whether extending the period of tube feeding after oesophagectomy leads to better nutritional status outcomes compared to current tube feeding length.
Interventions
Participants in this study will be fed enterally for a 12 weeks (intervention) with a nutritional supplement (such as Nutrison Protein Plus MultiFibre) providing 20kCal/kg energy and 1g/kg Protein per day as an overnight feed to supplement high protein, high energy oral diet. The feeding tube will be placed during surgery and the ward dietitian will commence the feeding regimen. Patients will be provided with a high energy, high protein diet of the appropriate texture while inpatients and the dietitian will provide education on how to optimise their oral intake at home prior to discharge. This is the current usual care for all patients after oesophagectomy.
Sponsors
Study design
Eligibility
Inclusion criteria
Patients with oesophageal cancer undergoing curative surgery at the John Hunter Hospital, NSW (ie patients undergoing surgery with a view to cure cancer rather than for palliative or short term treatment).
Exclusion criteria
Patients having non-curative surgery Patients being discharged to another facility other than home. Women who are pregnant would not generally be candidates for oesophageal cancer so would not be participants, additionally as an adult hospital, all patients will be aged > 18 years.